1. INNV-06. TREATMENT RESPONSE TO BEVACIZUMAB OVER TWO YEARS IN A PATIENT WITH GENETICALLY PROVEN SOMATIC NEUROFIBROMATOSIS TYPE 2 MOSAICISM. (11th November 2019) Authors: Basenach, Elena; Förster, Alisa; Raab, Peter; Alzein, Samer; Schmidt, Gunnar; Krauss, Joachim; Heidenreich, Fedor; Hartmann, Christian; Auber, Bernd; Wiese, Bettina; Weber, Ruthild Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗